XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients
Clinical trial NCT07381777 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381777
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2028-07-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.